These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 20113272

  • 1. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M, Sauter M, Argirov M, Wörnle M.
    Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
    [Abstract] [Full Text] [Related]

  • 2. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK.
    Catheter Cardiovasc Interv; 2002 Nov 04; 57(3):279-83. PubMed ID: 12410497
    [Abstract] [Full Text] [Related]

  • 4. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H.
    Ann Pharmacother; 2007 Jan 04; 41(1):46-50. PubMed ID: 17190844
    [Abstract] [Full Text] [Related]

  • 5. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
    Hoffmann U, Banas B, Fischereder M, Krämer BK.
    Kidney Blood Press Res; 2004 Jan 04; 27(3):161-6. PubMed ID: 15256811
    [Abstract] [Full Text] [Related]

  • 6. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 04; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 7. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
    Alioglu E, Saygi S, Turk U, Kirilmaz B, Tuzun N, Duman C, Tengiz I, Yildiz S, Ercan E.
    Cardiovasc Ther; 2013 Jun 04; 31(3):168-73. PubMed ID: 22212518
    [Abstract] [Full Text] [Related]

  • 8. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
    Duong MH, MacKenzie TA, Malenka DJ.
    Catheter Cardiovasc Interv; 2005 Apr 04; 64(4):471-9. PubMed ID: 15789388
    [Abstract] [Full Text] [Related]

  • 9. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O.
    Am Heart J; 2007 Sep 04; 154(3):539-44. PubMed ID: 17719303
    [Abstract] [Full Text] [Related]

  • 10. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.
    J Crit Care; 2013 Oct 04; 28(5):701-9. PubMed ID: 23683568
    [Abstract] [Full Text] [Related]

  • 11. N-Acetylcysteine does not artifactually lower plasma creatinine concentration.
    Haase M, Haase-Fielitz A, Ratnaike S, Reade MC, Bagshaw SM, Morgera S, Dragun D, Bellomo R.
    Nephrol Dial Transplant; 2008 May 04; 23(5):1581-7. PubMed ID: 18202091
    [Abstract] [Full Text] [Related]

  • 12. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado César LA, Seguro AC.
    Nephrol Dial Transplant; 2004 Jul 04; 19(7):1803-7. PubMed ID: 15128882
    [Abstract] [Full Text] [Related]

  • 13. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.
    J Assoc Physicians India; 2006 Jun 04; 54():449-52. PubMed ID: 16909692
    [Abstract] [Full Text] [Related]

  • 14. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ.
    Am Heart J; 2006 May 04; 151(5):1032.e9-12. PubMed ID: 16644332
    [Abstract] [Full Text] [Related]

  • 15. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 04; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 16. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.
    Minerva Cardioangiol; 2010 Feb 04; 58(1):35-40. PubMed ID: 20145594
    [Abstract] [Full Text] [Related]

  • 17. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
    Poletti PA, Saudan P, Platon A, Mermillod B, Sautter AM, Vermeulen B, Sarasin FP, Becker CD, Martin PY.
    AJR Am J Roentgenol; 2007 Sep 04; 189(3):687-92. PubMed ID: 17715118
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Manzone C, Amato M, Bellandi F.
    Am J Cardiol; 2010 Feb 01; 105(3):288-92. PubMed ID: 20102936
    [Abstract] [Full Text] [Related]

  • 19. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
    Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW.
    Am J Cardiol; 2004 Jun 15; 93(12):1515-9. PubMed ID: 15194023
    [Abstract] [Full Text] [Related]

  • 20. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
    Moist L, Sontrop JM, Gallo K, Mainra R, Cutler M, Freeman D, House AA.
    Am J Kidney Dis; 2010 Oct 15; 56(4):643-50. PubMed ID: 20541301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.